<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 10: Mean ± SD Levofloxacin PK Parameters</caption>
<col align="left" span="1" valign="middle" width="23%"></col>
<col align="center" span="1" valign="middle" width="11%"></col>
<col align="center" span="1" valign="middle" width="11%"></col>
<col align="center" span="1" valign="middle" width="11%"></col>
<col align="center" span="1" valign="middle" width="11%"></col>
<col align="center" span="1" valign="middle" width="11%"></col>
<col align="center" span="1" valign="middle" width="11%"></col>
<col align="center" span="1" valign="middle" width="11%"></col>
<tbody>
<tr>
<th colspan="1">Regimen</th>
<th colspan="1">C<sub>max</sub>
</th>
<th colspan="1">T<sub>max</sub>
</th>
<th colspan="1">AUC</th>
<th colspan="1">CL/F<linkhtml href="#footnote-1">*</linkhtml>
</th>
<th colspan="1">Vd/F<linkhtml href="#footnote-2">†</linkhtml>
</th>
<th colspan="1">t<sub>1/2</sub>
</th>
<th colspan="1">CL<sub>R</sub>
</th>
</tr>
<tr>
<th colspan="1">(mcg/mL)</th>
<th colspan="1">(h)</th>
<th colspan="1">(mcg∙h/mL)</th>
<th colspan="1">(mL/min)</th>
<th colspan="1">(L)</th>
<th colspan="1">(h)</th>
<th colspan="1">(mL/min)</th>
</tr>
<tr>
<td>
<content stylecode="bold">Single dose</content>
</td>
</tr>
<tr>
<td>250 mg oral tablet<linkhtml href="#footnote-3">‡</linkhtml>
</td>
<td>2.8 ± 0.4</td>
<td>1.6 ± 1.0</td>
<td>27.2 ± 3.9</td>
<td>156 ± 20</td>
<td>ND</td>
<td>7.3 ± 0.9</td>
<td>142 ± 21</td>
</tr>
<tr>
<td>500 mg oral tablet<footnoteref idref="F1"></footnoteref>
<linkhtml href="#footnote-4">§</linkhtml>
</td>
<td>5.1 ± 0.8</td>
<td>1.3 ± 0.6</td>
<td>47.9 ± 6.8</td>
<td>178 ± 28</td>
<td>ND</td>
<td>6.3 ± 0.6</td>
<td>103 ± 30</td>
</tr>
<tr>
<td>500 mg oral solution<linkhtml href="#footnote-5">¶</linkhtml>
</td>
<td>5.8 ± 1.8</td>
<td>0.8 ± 0.7</td>
<td>47.8 ± 10.8</td>
<td>183 ± 40</td>
<td>112 ± 37.2</td>
<td>7.0 ± 1.4</td>
<td>ND</td>
</tr>
<tr>
<td>500 mg IV<footnoteref idref="F1"></footnoteref>
</td>
<td>6.2 ± 1.0</td>
<td>1.0 ± 0.1</td>
<td>48.3 ± 5.4</td>
<td>175 ± 20</td>
<td>90 ± 11</td>
<td>6.4 ± 0.7</td>
<td>112 ± 25</td>
</tr>
<tr>
<td>750 mg oral tablet<linkhtml href="#footnote-6">#</linkhtml>
<footnoteref idref="F2"></footnoteref>
</td>
<td>9.3 ± 1.6</td>
<td>1.6 ± 0.8</td>
<td>101 ± 20</td>
<td>129 ± 24</td>
<td>83 ± 17</td>
<td>7.5 ± 0.9</td>
<td>ND</td>
</tr>
<tr>
<td>750 mg IV<footnoteref idref="F3"></footnoteref>
</td>
<td>11.5 ± 4.0<linkhtml href="#footnote-7">Þ</linkhtml>
</td>
<td>ND</td>
<td>110 ± 40</td>
<td>126 ± 39</td>
<td>75 ± 13</td>
<td>7.5 ± 1.6</td>
<td>ND</td>
</tr>
<tr>
<td>
<content stylecode="bold">Multiple dose</content>
</td>
</tr>
<tr>
<td>500 mg every 24h oral tablet<footnoteref idref="F1"></footnoteref>
</td>
<td>5.7 ± 1.4</td>
<td>1.1 ± 0.4</td>
<td>47.5 ± 6.7</td>
<td>175 ± 25</td>
<td>102 ± 22</td>
<td>7.6 ± 1.6</td>
<td>116 ± 31</td>
</tr>
<tr>
<td>500 mg every 24h IV<footnoteref idref="F1"></footnoteref>
</td>
<td>6.4 ± 0.8</td>
<td>ND</td>
<td>54.6 ± 11.1</td>
<td>158 ± 29</td>
<td>91 ± 12</td>
<td>7.0 ± 0.8</td>
<td>99 ± 28</td>
</tr>
<tr>
<td>500 mg or 250 mg every 24h IV, patients with bacterial infection<linkhtml href="#footnote-8">ß</linkhtml>
</td>
<td>8.7± 4.0<linkhtml href="#footnote-9">à</linkhtml>
</td>
<td>ND</td>
<td>72.5 ± 51.2<footnoteref idref="F5"></footnoteref>
</td>
<td>154 ± 72</td>
<td>111 ± 58</td>
<td>ND</td>
<td>ND</td>
</tr>
<tr>
<td>750 mg every 24h oral tablet<footnoteref idref="F3"></footnoteref>
</td>
<td>8.6 ± 1.9</td>
<td>1.4 ± 0.5</td>
<td>90.7 ± 17.6</td>
<td>143 ± 29</td>
<td>100 ± 16</td>
<td>8.8 ± 1.5</td>
<td>116 ± 28</td>
</tr>
<tr>
<td>750 mg every 24h IV<footnoteref idref="F3"></footnoteref>
</td>
<td>12.1 ± 4.1<footnoteref idref="F4"></footnoteref>
</td>
<td>ND</td>
<td>108 ± 34</td>
<td>126 ± 37</td>
<td>80 ± 27</td>
<td>7.9 ± 1.9</td>
<td>ND</td>
</tr>
<tr>
<td>
<content stylecode="bold">500 mg oral tablet single dose, effects of gender and age:</content>
</td>
</tr>
<tr>
<td>Male<linkhtml href="#footnote-10">è</linkhtml>
</td>
<td>5.5 ± 1.1</td>
<td>1.2 ± 0.4</td>
<td>54.4 ± 18.9</td>
<td>166 ± 44</td>
<td>89 ± 13</td>
<td>7.5 ± 2.1</td>
<td>126 ± 38</td>
</tr>
<tr>
<td>Female<linkhtml href="#footnote-11">ð</linkhtml>
</td>
<td>7.0 ± 1.6</td>
<td>1.7 ± 0.5</td>
<td>67.7 ± 24.2</td>
<td>136 ± 44</td>
<td>62 ± 16</td>
<td>6.1 ± 0.8</td>
<td>106 ± 40</td>
</tr>
<tr>
<td>Young<linkhtml href="#footnote-12">ø</linkhtml>
</td>
<td>5.5 ± 1.0</td>
<td>1.5 ± 0.6</td>
<td>47.5 ± 9.8</td>
<td>182 ± 35</td>
<td>83 ± 18</td>
<td>6.0 ± 0.9</td>
<td>140 ± 33</td>
</tr>
<tr>
<td>Elderly<linkhtml href="#footnote-13">ý</linkhtml>
</td>
<td>7.0 ± 1.6</td>
<td>1.4 ± 0.5</td>
<td>74.7 ± 23.3</td>
<td>121 ± 33</td>
<td>67 ± 19</td>
<td>7.6 ± 2.0</td>
<td>91 ± 29</td>
</tr>
<tr>
<td>
<content stylecode="bold">500 mg oral single dose tablet, patients with renal insufficiency:</content>
</td>
</tr>
<tr>
<td>CLCR 50–80 mL/min</td>
<td>7.5 ± 1.8</td>
<td>1.5 ± 0.5</td>
<td>95.6 ± 11.8</td>
<td>88 ± 10</td>
<td>ND</td>
<td>9.1 ± 0.9</td>
<td>57 ± 8</td>
</tr>
<tr>
<td>CLCR 20–49 mL/min</td>
<td>7.1 ± 3.1</td>
<td>2.1 ± 1.3</td>
<td>182.1 ± 62.6</td>
<td>51 ± 19</td>
<td>ND</td>
<td>27 ± 10</td>
<td>26 ± 13</td>
</tr>
<tr>
<td>CLCR &lt;20 mL/min</td>
<td>8.2 ± 2.6</td>
<td>1.1 ± 1.0</td>
<td>263.5 ± 72.5</td>
<td>33 ± 8</td>
<td>ND</td>
<td>35 ± 5</td>
<td>13 ± 3</td>
</tr>
<tr>
<td>Hemodialysis</td>
<td>5.7 ± 1.0</td>
<td>2.8 ± 2.2</td>
<td>ND</td>
<td>ND</td>
<td>ND</td>
<td>76 ± 42</td>
<td>ND</td>
</tr>
<tr>
<td>CAPD</td>
<td>6.9 ± 2.3</td>
<td>1.4 ± 1.1</td>
<td>ND</td>
<td>ND</td>
<td>ND</td>
<td>51 ± 24</td>
<td>ND</td>
</tr>
</tbody>
</table>